Clinical Trial on the Use of Stratafix Symmetric vs. Resorbable Monofilament for Closure of Large Median Laparotomy in Oncological Patients
ONCOSTRAT
1 other identifier
interventional
140
1 country
1
Brief Summary
The aim of this study is to evaluate the safety and efficacy of using Stratafix (a type of symmetric, barbed, and coated suture) for abdominal wall closure in oncologic patients undergoing elective midline laparotomy, compared to the use of a monofilament suture following the Small Stitch technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 21, 2025
CompletedFirst Submitted
Initial submission to the registry
October 16, 2025
CompletedFirst Posted
Study publicly available on registry
October 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2028
October 20, 2025
July 1, 2025
2.8 years
October 16, 2025
October 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incisional hernia
Incisional hernia rate after midline laparotomy closure.
12 months
Secondary Outcomes (4)
Wound infection
12 months.
Wound seroma
12 months
Hematoma
12 months
Evisceration
1 month
Study Arms (2)
Stratafix
EXPERIMENTALMidline laparotomy closure with Stratafix suture.
PDS plus
ACTIVE COMPARATORMidline laparotomy closure with PDS plus suture
Interventions
Eligibility Criteria
You may qualify if:
- Patients over 18 years of age who will undergo midline laparotomy for oncologic resection of a retroperitoneal tumor or cytoreductive surgery for carcinomatosis of any origin.
You may not qualify if:
- Diagnosed incisional hernia.
- When the planned midline laparotomy is expected to be less than 20 cm.
- Patients with a BMI \> 45 kg/m².
- Patients with abdominal aortic aneurysm.
- Patients with coagulopathy: previously diagnosed with von Willebrand disease, hemophilia, or idiopathic thrombocytopenic purpura.
- Patients with collagen disorders: previously diagnosed with Marfan syndrome, Ehlers-Danlos syndrome, homocystinuria, or scleroderma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2025
First Posted
October 20, 2025
Study Start
May 21, 2025
Primary Completion (Estimated)
February 28, 2028
Study Completion (Estimated)
February 28, 2028
Last Updated
October 20, 2025
Record last verified: 2025-07